AlenCiken

In-Line Q4 EPS Analyst Sees Better 2nd-Half

Long
NYSE:CSLT   None
Castlight Health (NYSE: CSLT) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $40.47 million.

GUIDANCE:

Castlight Health sees FY2019 EPS of $0.00-$0.03, versus the consensus of $0.01. Castlight Health sees FY2019 revenue of $153-158 million, versus the consensus of $159.77 million.

www.barchart.com/sto...s-whats-in-the-cards

www.fool.com/investi...ed-24-on-friday.aspx


Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.